T. Rowe Price Investment Management, Inc. 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | BIOLIFE SOLUTIONS INC BLFS | T. Rowe Price Investment Management, Inc. | 6,506,346 13.500% | 1,325,522 (+25.59%) | Filing |
| 2026-01-08 12:15 pm Purchase | 2025-12-31 | 13G | BIOLIFE SOLUTIONS INC BLFS | T. Rowe Price Investment Management, Inc. | 5,180,824 10.800% | 934,118 (+22.00%) | Filing |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | BIOLIFE SOLUTIONS INC BLFS | T. Rowe Price Investment Management, Inc. | 4,246,706 8.900% | 4,246,706 (New Position) | Filing |